MIAMI, January 4, 2023 – Ostro, a leading healthcare interaction platform for consumers and HCPs, celebrated several key milestones in 2022, including yearly revenue growth of more than 250%, Series B investment, a new website, and brand design, and a Forbes mention for co-founder Ahmed Elsayyad.
Chase Feiger, MD, Ostro’s CEO remarked :
“I’ve never been more excited about Ostro’s future than I am. When my co-founders and I founded this firm, we felt we could transform the way life sciences commercialization is approached by focusing on consumerization, personalization, and engagement. This year, the entire industry began to turn in that way.”
In 2022, Ostro collaborated with many brands from the top 10, mid-size, and smaller life sciences organizations, including pharmaceutical, biotech, medical device, and digital therapeutics, to address multiple use cases in neurology, cardiovascular disease, pulmonology, infectious disease, women’s health, and more. Simultaneously, Ostro launched a new website and brand identity, increased its employee base by 50%, and raised an additional USD 45 million in funding from Founders Fund, Byers Capital, Caffeinated Capital, Greycroft, Bling Capital, Trust Ventures, and RRE Ventures, bringing total funding to more than USD 55 million.
In addition to its rapid expansion, the Ostro team recently received a major honor: co-founder and President Ahmed Elsayyad was nominated on Forbes’ 30 Under 30 list for healthcare.
“No one deserves it more than Ahmed,” Feiger remarked. “He’s been laser-focused on selflessly bringing value to patients and HCPs for as long as I’ve known him. I’m thrilled he’s getting acknowledged for his services to the business.”
In 2023, Ostro plans to build on its success in 2022 by expanding its customer base, expanding its product range, and growing the Ostro team.
More about the company:
Ostro was formed to assist millions of people in living better lives by developing customized healthcare journeys that increase consumer and HCP engagement while driving value for life sciences firms. Ostro Navigate is a 1:1 experience that provides consumers and HCPs with a personalized journey to help address their needs; Ostro Attribute is an analytics product that connects brand marketing campaigns to clinical outcomes to increase the impact of commercial spending; and Ostro Consult is a telehealth experience that supports the engagement journey by connecting patients to an experienced and qualified clinician.
We try our best to fact-check and bring the best, well-researched, and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
